{
  "id": 13595390,
  "title": "Onemednet CEO Aaron Green sells $47,762 in company stock",
  "url": "https://urgent.news/2026/10/11/onemednet-ceo-aaron-green-sells-47-762-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-11T00:16:01.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/onemednet-ceo-aaron-green-sells-47762-in-company-stock-93CH-4942347"
  },
  "original_language": "en",
  "account": "OneMedNet CEO Aaron Green recently disposed of $47,762 worth of company stock, as disclosed in a recent SEC filing. The transactions took place on September 22 and September 24, 2026, with share prices fluctuating between $6.48 and $7.392 per share. Since then, the stock has experienced a significant decline, currently trading at $4.30, representing a 20% drop over the past week. According to InvestingPro analysis, the stock appears undervalued at present, having decreased by 86% over the past year.\n\nOn September 22, Green sold 5,000 shares at the higher price of $7.392 each. Two days later, on September 24, he disposed of an additional 1,667 shares at $6.48 per share, both transactions likely tied to covering tax obligations related to the vesting and settlement of his Restricted Stock Units (RSUs). Earlier, on July 6, 2026, Green had acquired 65,000 shares of OneMedNet's common stock at $0 per share, as part of RSUs granted under the company's 2022 Equity Incentive Plan. The RSUs allow for the contingent receipt of one share for each unit, with vesting in three equal installments over 24 months, contingent upon continued service.\n\nAfter these transactions, Aaron Green now directly owns 247,971 shares of OneMedNet Corporation common stock, following a 1-for-10 reverse stock split executed on September 29, 2026.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock",
        "url": "https://urgent.news/2026/10/10/rapport-therapeutics-ceo-abraham-ceesay-sells-143-272-in-stock",
        "published": "2026-10-10T17:31:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}